BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 26978429)

  • 1. FP-CIT- and IBZM-SPECT in Corticobasal Syndrome: Results from a Clinical Follow-Up Study.
    Hammesfahr S; Antke C; Mamlins E; Beu M; Wojtecki L; Ferrea S; Dinkelbach L; Moldovan AS; Schnitzler A; Müller HW; Südmeyer M
    Neurodegener Dis; 2016; 16(5-6):342-7. PubMed ID: 26978429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic value of asymmetric striatal D2 receptor upregulation in Parkinson's disease: an [123I]IBZM and [123I]FP-CIT SPECT study.
    Verstappen CC; Bloem BR; Haaxma CA; Oyen WJ; Horstink MW
    Eur J Nucl Med Mol Imaging; 2007 Apr; 34(4):502-7. PubMed ID: 17053905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence of delayed nigrostriatal dysfunction in corticobasal syndrome: a SPECT follow-up study.
    Ceravolo R; Rossi C; Cilia R; Tognoni G; Antonini A; Volterrani D; Bonuccelli U
    Parkinsonism Relat Disord; 2013 May; 19(5):557-9. PubMed ID: 23433820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined 123I-FP-CIT and 123I-IBZM SPECT for the diagnosis of parkinsonian syndromes: study on 72 patients.
    Plotkin M; Amthauer H; Klaffke S; Kühn A; Lüdemann L; Arnold G; Wernecke KD; Kupsch A; Felix R; Venz S
    J Neural Transm (Vienna); 2005 May; 112(5):677-92. PubMed ID: 15375677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study.
    Iranzo A; Valldeoriola F; Lomeña F; Molinuevo JL; Serradell M; Salamero M; Cot A; Ros D; Pavía J; Santamaria J; Tolosa E
    Lancet Neurol; 2011 Sep; 10(9):797-805. PubMed ID: 21802993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of Follow-up Dopamine Transporter SPECT With 123I-FP-CIT in the Diagnostic Workup of Patients With Clinically Uncertain Parkinsonian Syndrome.
    Apostolova I; Taleb DS; Lipp A; Galazky I; Kupitz D; Lange C; Makowski MR; Brenner W; Amthauer H; Plotkin M; Buchert R
    Clin Nucl Med; 2017 Aug; 42(8):589-594. PubMed ID: 28574876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine Transporter SPECT Imaging in Corticobasal Syndrome.
    Cilia R; Rossi C; Frosini D; Volterrani D; Siri C; Pagni C; Benti R; Pezzoli G; Bonuccelli U; Antonini A; Ceravolo R
    PLoS One; 2011 May; 6(5):e18301. PubMed ID: 21559307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [123I]FP-CIT SPECT in Clinically Uncertain Parkinsonism Predicts Survival: A Data-Driven Analysis.
    Frings L; Henninger F; Treppner M; Köber G; Boeker M; Hellwig S; Buchert R; Meyer PT
    J Parkinsons Dis; 2020; 10(4):1457-1465. PubMed ID: 33044193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progression of dopaminergic degeneration in Parkinson's disease and atypical parkinsonism: a longitudinal beta-CIT SPECT study.
    Pirker W; Djamshidian S; Asenbaum S; Gerschlager W; Tribl G; Hoffmann M; Brücke T
    Mov Disord; 2002 Jan; 17(1):45-53. PubMed ID: 11835438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iodine-123-N-omega-fluoropropyl-2beta-carbomethoxy-3beta-(4-iod ophenyl)tropane SPECT in healthy controls and early-stage, drug-naive Parkinson's disease.
    Tissingh G; Booij J; Bergmans P; Winogrodzka A; Janssen AG; van Royen EA; Stoof JC; Wolters EC
    J Nucl Med; 1998 Jul; 39(7):1143-8. PubMed ID: 9669384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 123I-beta-CIT and 123I-IBZM-SPECT scanning in levodopa-naive Parkinson's disease.
    Wenning GK; Donnemiller E; Granata R; Riccabona G; Poewe W
    Mov Disord; 1998 May; 13(3):438-45. PubMed ID: 9613734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic accuracy of combined FP-CIT, IBZM, and MIBG scintigraphy in the differential diagnosis of degenerative parkinsonism: a multidimensional statistical approach.
    Südmeyer M; Antke C; Zizek T; Beu M; Nikolaus S; Wojtecki L; Schnitzler A; Müller HW
    J Nucl Med; 2011 May; 52(5):733-40. PubMed ID: 21498527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging of dopamine transporters with iodine-123-FP-CIT SPECT in healthy controls and patients with Parkinson's disease.
    Booij J; Habraken JB; Bergmans P; Tissingh G; Winogrodzka A; Wolters EC; Janssen AG; Stoof JC; van Royen EA
    J Nucl Med; 1998 Nov; 39(11):1879-84. PubMed ID: 9829575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine transporters, D2 receptors, and glucose metabolism in corticobasal degeneration.
    Klaffke S; Kuhn AA; Plotkin M; Amthauer H; Harnack D; Felix R; Kupsch A
    Mov Disord; 2006 Oct; 21(10):1724-7. PubMed ID: 16773621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Precise Evaluation of Striatal Oxidative Stress Corrected for Severity of Dopaminergic Neuronal Degeneration in Patients with Parkinson's Disease: A Study with 62Cu-ATSM PET and 123I-FP-CIT SPECT.
    Neishi H; Ikawa M; Okazawa H; Tsujikawa T; Arishima H; Kikuta KI; Yoneda M
    Eur Neurol; 2017; 78(3-4):161-168. PubMed ID: 28848099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Striatal dopamine transporter levels in patients with REM sleep behavior disorder: assessment with 123I-FP-CIT SPECT].
    Mossa EP; Niccoli Asabella A; Iuele F; Stabile Ianora AA; Giganti M; Rubini G
    Recenti Prog Med; 2012 Nov; 103(11):500-4. PubMed ID: 23096739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of dopamine-D2 receptor binding sites in Parkinsonian plus syndromes.
    Hierholzer J; Cordes M; Venz S; Schelosky L; Harisch C; Richter W; Keske U; Hosten N; Mäurer J; Poewe W; Felix R
    J Nucl Med; 1998 Jun; 39(6):954-60. PubMed ID: 9627325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine transporter imaging and the effects of deep brain stimulation in patients with Parkinson's disease.
    Lokkegaard A; Werdelin LM; Regeur L; Karlsborg M; Jensen SR; Brødsgaard E; Madsen FF; Lonsdale MN; Friberg L
    Eur J Nucl Med Mol Imaging; 2007 Apr; 34(4):508-16. PubMed ID: 17096096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Classification of degenerative parkinsonism subtypes by support-vector-machine analysis and striatal
    Nicastro N; Wegrzyk J; Preti MG; Fleury V; Van de Ville D; Garibotto V; Burkhard PR
    J Neurol; 2019 Jul; 266(7):1771-1781. PubMed ID: 31037416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SPECT study of the nigrostriatal dopaminergic system in Huntington's disease.
    Hwang WJ; Yao WJ
    J Neuroimaging; 2013 Apr; 23(2):192-6. PubMed ID: 22211920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.